Stem Cell Research (May 2022)

Human induced pluripotent stem cells derived from a patient with a mutation of FBN1c.1858C > T (p. Pro620Ser)

  • Aiqi Lin,
  • Xiaocui Kang,
  • Yi Xu,
  • Xiaochao Feng,
  • Shufan Zhang,
  • Hongchen Zhao,
  • Danhong Wu,
  • Xiang Han

Journal volume & issue
Vol. 61
p. 102759

Abstract

Read online

Mutation of FBN1 has certain relation with the incidence of cranial cervical artery dissection. Our study reprogrammed human induced pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells (PBMC) of a patient with a mutation of FBN1c.1858C > T (p. Pro620Ser). The generated iPSCs express pluripotent cell markers with no mycoplasma contamination. Besides, it has normal karyotype and could differentiate into mesoderm, endoderm and neuronal layers. We also identified it has the same specific mutation with our patient.